Q2 2026 saw 8.5% revenue growth and a return to profitability, driven by organic gains, acquisitions, and favorable currency impacts. Segment performance was strong, especially in Precision and Science Technologies, while free cash flow remained stable. Key risks include macroeconomic uncertainty, FX volatility, and ongoing integration of acquisitions.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.